Michael D'alessandro
About Michael D'alessandro
Michael D'alessandro is the Sr. Manager of CAR-T P&T Operations Support at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in CAR-T cell therapy operations.
Title
Michael D'alessandro serves as the Sr. Manager of CAR-T P&T Operations Support at Bristol Myers Squibb. He is based in Summit, New Jersey, United States.
Current Role at Bristol Myers Squibb
In his current role as Sr. Manager, CAR-T P&T Operations Support at Bristol Myers Squibb, Michael D'alessandro is responsible for overseeing various aspects of CAR-T cell therapy operations. This position involves ensuring the efficiency and effectiveness of production processes to support therapeutic advancements.
Professional Experience
Michael D'alessandro has gathered substantial experience in the pharmaceutical and biopharmaceutical industries. His professional journey includes various roles at Bristol Myers Squibb and Celgene. Notably, he worked as Principal Specialist at Bristol Myers Squibb from 2020 to 2021 and held multiple positions at Celgene, such as Process Engineer II, Manufacturing Supervisor, Specialist, and Manufacturing Associate from 2016 to 2020. Additionally, Michael has experience as a Process Engineer and Process Specialist at Hovione and as a Research Scientist I at AMRI.
Education and Expertise
Michael D'alessandro earned both his Bachelor's and Master's degrees in Pharmaceutical Sciences from Albany College of Pharmacy and Health Sciences. The academic background, focusing on pharmaceutical sciences, has enabled him to apply his research skills and theoretical knowledge effectively in various professional roles, particularly in CAR-T cell therapy operations and process engineering.
Background in Process Engineering and Biopharmaceutical Manufacturing
Michael D'alessandro has a solid foundation in process engineering and biopharmaceutical manufacturing. His career trajectory includes significant roles that demonstrate a shift from traditional process engineering at Hovione to more specialized biopharmaceutical manufacturing and CAR-T therapies at Celgene and Bristol Myers Squibb. His background blends both research and applied science, making him a versatile professional in his field.